Recruiting at 1 site Phase 3 Nicotine Dependence

Clinical trial for Nicotine Dependence

Official title Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.

ClinicalTrials.gov ID: NCT06053567

What this study is testing

What is Nicotine patch?

An investigational transdermal nicotine patch being studied as a potential aid for smoking cessation. It is designed to deliver nicotine through the skin to reduce withdrawal symptoms.

Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
This study is testing whether a quit program that is personalized for people with high anxiety sensitivity works in a YMCA setting.
Who it's for
You may be able to join if you are an adult who smokes and often feel scared by your own body sensations, and you live in a community with a YMCA.
What's involved
You will receive a quit program that is adapted to your anxiety sensitivity. You will attend sessions at the YMCA and may do some simple tests or questionnaires.
Time commitment
The study lasts several weeks, with regular visits to the YMCA for support and check‑ins.
  • Phase 3: a large, late-stage study

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older. Healthy volunteers may be eligible.

You may be able to join if

  • Adult (age ≥ 18);
  • High Anxiety Sensitivity (≥5 on the Short Scale Anxiety Sensitivity Index [SSASI]);
  • Daily smoker, ≥5 cigarettes (including e-cigarettes, little cigars/cigarillos) for ≥1 year;
  • Motivated to quit smoking as evidenced by a score of ≥5 on a 0-10 Likert scale;
  • Body mass index \< 40;

You likely can't join if

  • Regular exercise defined as engaging in vigorous-intensity exercise for at least 75 minutes per week for the last 3 months
  • Receiving current intervention for smoking cessation.
  • Outstanding debt to the YMCA
  • Listed as a sex offender on the National Sex Offender Registry
See the full eligibility criteria
Who can join
  • Adult (age ≥ 18);
  • High Anxiety Sensitivity (≥5 on the Short Scale Anxiety Sensitivity Index [SSASI]);
  • Daily smoker, ≥5 cigarettes (including e-cigarettes, little cigars/cigarillos) for ≥1 year;
  • Motivated to quit smoking as evidenced by a score of ≥5 on a 0-10 Likert scale;
  • Body mass index \< 40;
  • Medical clearance to participate.
  • Located near a participating YMCA site (within 50 miles)
What rules you out
  • Regular exercise defined as engaging in vigorous-intensity exercise for at least 75 minutes per week for the last 3 months
  • Receiving current intervention for smoking cessation.
  • Outstanding debt to the YMCA
  • Listed as a sex offender on the National Sex Offender Registry

The study team makes the final eligibility decision.

Where it is enrolling

  • Austin, Texas, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Austin, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.